FlaggedRx← Medication recall checkHome
Class II · ModerateActive recall

Azacitidine for Injection 100mg/Vial

Could cause temporary or reversible harm; serious harm is unlikely.

Does this affect you?
Check your lot numberLot, expiry: RAZM0425A Jun 30, 2027; RAZM0525A Jun 30, 2027; RAZM0725A Jun 30, 2027; RAZM0825A Jun 30, 2027; RAZM0925A Jul 31, 2027; RAZM1125A Jul 31, 2027; RAZM1225A Jul 31, 2027; RAZM1425A Jul 31, 2027; RAZM1525A Jul 31, 2027; RAZM1625A Aug 31, 2027; RAZM1725A Aug 31, 2027; RAZM2025A Sep 30, 2027
Where it was soldNationwide in the USA
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

Lack of Sterility Assurance

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Distributed by / forSomerset Therapeutics, LLC., Somerset, NJ 08873
NDC70069-0857-01
Show the full FDA record
Full product labelAzacitidine for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For Subcutaneous and Intravenous Use, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0857-01
Recalling firmReliance Life Sciences Private Limited
DistributionNationwide in the USA
Quantity8,001 vials
Recall initiated2026-06-24
Report date2026-07-15
Recall completed
Recall numberD-0674-2026
ClassificationClass II
FDA statusOngoing
Origin on fileNavi Mumbai N/A India

Related

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.